Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy
Standard
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy. / Beckmann, Matthias; Stübs, Frederik A; Koch, Martin C; Mallmann, Peter; Dannecker, Christian; Dietl, Anna; Sevnina, Anna; Mergel, Franziska; Lotz, Laura; Hack, Carolin C; Ehret, Anne; Gantert, Daniel; Martignoni, Franca; Cieslik, Jan-Philipp; Menke, Jan; Ortmann, Olaf; Stromberger, Carmen; Oechsle, Karin; Hornemann, Beate; Mumm, Friederike; Grimm, Christoph; Sturdza, Alina; Wight, Edward; Loessl, Kristina; Golatta, Michael; Hagen, Volker; Dauelsberg, Timm; Diel, Ingo; Münstedt, Karsten; Merz, Eberhard; Vordermark, Dirk; Lindel, Katja; Wittekind, Christian; Küppers, Volkmar; Lellé, Ralph; Neis, Klaus; Griesser, Henrik; Pöschel, Birgit; Steiner, Manfred; Freitag, Ulrich; Gilster, Tobias; Schmittel, Alexander; Friedrich, Michael; Haase, Heidemarie; Gebhardt, Marion; Kiesel, Ludwig; Reinhardt, Michael; Kreißl, Michael; Kloke, Marianne; Horn, Lars-Christian; Wiedemann, Regina; Marnitz, Simone; Letsch, Anne; Zraik, Isabella; Mangold, Bernhard; Möckel, Jochen; Alt, Céline; Wimberger, Pauline; Hillemanns, Peter; Paradies, Kerstin; Mustea, Alexander; Denschlag, Dominik; Henscher, Ulla; Tholen, Reina; Wesselmann, Simone; Fehm, Tanja.
In: GEBURTSH FRAUENHEILK, Vol. 82, No. 2, 02.2022, p. 139-180.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy
AU - Beckmann, Matthias
AU - Stübs, Frederik A
AU - Koch, Martin C
AU - Mallmann, Peter
AU - Dannecker, Christian
AU - Dietl, Anna
AU - Sevnina, Anna
AU - Mergel, Franziska
AU - Lotz, Laura
AU - Hack, Carolin C
AU - Ehret, Anne
AU - Gantert, Daniel
AU - Martignoni, Franca
AU - Cieslik, Jan-Philipp
AU - Menke, Jan
AU - Ortmann, Olaf
AU - Stromberger, Carmen
AU - Oechsle, Karin
AU - Hornemann, Beate
AU - Mumm, Friederike
AU - Grimm, Christoph
AU - Sturdza, Alina
AU - Wight, Edward
AU - Loessl, Kristina
AU - Golatta, Michael
AU - Hagen, Volker
AU - Dauelsberg, Timm
AU - Diel, Ingo
AU - Münstedt, Karsten
AU - Merz, Eberhard
AU - Vordermark, Dirk
AU - Lindel, Katja
AU - Wittekind, Christian
AU - Küppers, Volkmar
AU - Lellé, Ralph
AU - Neis, Klaus
AU - Griesser, Henrik
AU - Pöschel, Birgit
AU - Steiner, Manfred
AU - Freitag, Ulrich
AU - Gilster, Tobias
AU - Schmittel, Alexander
AU - Friedrich, Michael
AU - Haase, Heidemarie
AU - Gebhardt, Marion
AU - Kiesel, Ludwig
AU - Reinhardt, Michael
AU - Kreißl, Michael
AU - Kloke, Marianne
AU - Horn, Lars-Christian
AU - Wiedemann, Regina
AU - Marnitz, Simone
AU - Letsch, Anne
AU - Zraik, Isabella
AU - Mangold, Bernhard
AU - Möckel, Jochen
AU - Alt, Céline
AU - Wimberger, Pauline
AU - Hillemanns, Peter
AU - Paradies, Kerstin
AU - Mustea, Alexander
AU - Denschlag, Dominik
AU - Henscher, Ulla
AU - Tholen, Reina
AU - Wesselmann, Simone
AU - Fehm, Tanja
N1 - Thieme. All rights reserved.
PY - 2022/2
Y1 - 2022/2
N2 - Aim This update of the interdisciplinary S3 guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL) was published in March 2021. This updated guideline was funded by German Cancer Aid (Deutsche Krebshilfe) as part of the German Guideline Program in Oncology. The guideline was coordinated by the German Society of Gynecology and Obstetrics ( Deutsche Gesellschaft für Gynäkologie und Geburtshilfe , DGGG) and the Working Group on Gynecological Oncology ( Arbeitsgemeinschaft Gynäkologische Onkologie , AGO) of the German Cancer Society ( Deutsche Krebsgesellschaft , DKG). Method The process of updating the S3 guideline dating from 2014 was based on an appraisal of the available evidence using the criteria of evidence-based medicine, adaptations of existing evidence-based national and international guidelines or - if evidence was lacking - on a consensus of the specialists involved in compiling the update. After an initial review of the current literature was carried out according to a prescribed algorithm, several areas were identified which, in contrast to the predecessor version from September 2014, required new recommendations or statements which took account of more recently published literature and the appraisal of the new evidence. Recommendations The short version of this guideline consists of recommendations and statements on the epidemiology, screening, diagnostic workup and therapy of patients with cervical cancer. The most important new aspects included in this updated guideline include the newly published FIGO classification of 2018, the radical open surgery approach for cervical cancers up to FIGO stage IB1, and use of the sentinel lymph node technique for tumors ≤ 2 cm. Other changes include the use of PET-CT, new options in radiotherapy (e.g., intensity-modulated radiotherapy, image-guided adaptive brachytherapy), and drug therapies to treat recurrence or metastasis.
AB - Aim This update of the interdisciplinary S3 guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL) was published in March 2021. This updated guideline was funded by German Cancer Aid (Deutsche Krebshilfe) as part of the German Guideline Program in Oncology. The guideline was coordinated by the German Society of Gynecology and Obstetrics ( Deutsche Gesellschaft für Gynäkologie und Geburtshilfe , DGGG) and the Working Group on Gynecological Oncology ( Arbeitsgemeinschaft Gynäkologische Onkologie , AGO) of the German Cancer Society ( Deutsche Krebsgesellschaft , DKG). Method The process of updating the S3 guideline dating from 2014 was based on an appraisal of the available evidence using the criteria of evidence-based medicine, adaptations of existing evidence-based national and international guidelines or - if evidence was lacking - on a consensus of the specialists involved in compiling the update. After an initial review of the current literature was carried out according to a prescribed algorithm, several areas were identified which, in contrast to the predecessor version from September 2014, required new recommendations or statements which took account of more recently published literature and the appraisal of the new evidence. Recommendations The short version of this guideline consists of recommendations and statements on the epidemiology, screening, diagnostic workup and therapy of patients with cervical cancer. The most important new aspects included in this updated guideline include the newly published FIGO classification of 2018, the radical open surgery approach for cervical cancers up to FIGO stage IB1, and use of the sentinel lymph node technique for tumors ≤ 2 cm. Other changes include the use of PET-CT, new options in radiotherapy (e.g., intensity-modulated radiotherapy, image-guided adaptive brachytherapy), and drug therapies to treat recurrence or metastasis.
U2 - 10.1055/a-1671-2158
DO - 10.1055/a-1671-2158
M3 - Other (editorial matter etc.)
C2 - 35169387
VL - 82
SP - 139
EP - 180
JO - GEBURTSH FRAUENHEILK
JF - GEBURTSH FRAUENHEILK
SN - 0016-5751
IS - 2
ER -